BAILLIE GIFFORD & CO

Holdings History for Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA)

Symbol: DNA on NYSE
Investment type: Equity / Class A Common Stock
Latest Disclosed Shares Owned: 2,391,649 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

BAILLIE GIFFORD & CO ownership in Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA)

05 Feb 2026 - BAILLIE GIFFORD & CO has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,391,649 shares of Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA). This represents 4.9% ownership of the company. This is the first filing by BAILLIE GIFFORD & CO disclosing ownership of Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BAILLIE GIFFORD & CO	4.9%		$19,874,603	2,391,649			$8.31	13G/A	31 Dec 2025	05 Feb 2026, 10:10

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	-0.01%	$19,874,603	2,391,649	-843,605	-26%	$8.31	Q4 2025
30 Sep 2025	0.03%	-0%	$47,170,004	3,235,254	-40,797	-1.2%	$14.58	Q3 2025
30 Jun 2025	0.03%	-0%	$36,855,574	3,276,051	-74,840	-2.2%	$11.25	Q2 2025
31 Mar 2025	0.02%	-0%	$19,100,078	3,350,891	-6,495		$5.70	Q1 2025
31 Dec 2024	0.03%	-0%	$32,969,531	3,357,386	-1,195	-0.04%	$9.82	Q4 2024
30 Sep 2024	0.02%	+0.02%	$27,372,435	3,358,581	+3,358,581	NEW	$8.15	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.